BELLEĞİN EPİGENETİK DÜZENLENMESİ: MİKRORNA’LARIN ROLÜ
Yıl 2018,
Cilt: 27 Sayı: 1, 87 - 94, 01.03.2018
Sebahattin Karabulut
Keziban Korkmaz Bayramov
Asuman Gölgeli
Öz
“MikroRNA(miRNA)’lar” kodlanmayan RNA’lar sınıfına
ait moleküller olup, protein sentezinin transkripsiyon
sonrası (posttranskripsiyonel) düzenleyicileri olarak
tanımlanırlar. Bu posttranskripsiyonel düzenlemenin
neredeyse tüm biyolojik süreçlerde rol oynadığı düşünülmektedir. Son zamanlarda miRNA aracılı bu regülasyonun, aktivite bağımlı gen ekspresyonunun yer aldığı
öğrenme ve bellek oluşumu için de kritik olduğu anlaşılmıştır. Bu endojen RNA’ların sadece öğrenme ve bellek
gibi normal beyin fonksiyonlarında değil, aynı zamanda
bilişsel işlevlerin etkilendiği çok sayıda nörodejeneratif
hastalığın fizyopatolojisinde de işe karıştığı gösterilmiştir. Bu derlemede miRNA’ların sinaptik plastisitedeki
rolleri ve bazı nörodejeneratif hastalıklarla ilişkileri ele
alınmıştır. Nöral plastisitede miRNA’ların rollerinin tam
olarak anlaşılması, bellek fonksiyonlarının bozulduğu
nörolojik hastalıklar için genetik tedavilerin ve yeni
teşhis yöntemlerinin gelişimine kapı açabilecektir.”
Kaynakça
- 1. Benington JH, Frank MG. Cellular and molecular
connections between sleep and synaptic plasticity.
Prog Neurobiol 2003; 69:71-101.
- 2. Davis HP, Squire LR. Protein synthesis and
memory: a review. Psychol Bull 1984; 96:518-559.
- 3. Sutton MA, Schuman EM. Dendritic protein
synthesis, synaptic plasticity, and memory. Cell
2006; 127:49-58.
- 4. Bartel DP. MicroRNAs: genomics, biogenesis,
mechanism, and function. Cell 2004; 116:281-297.
- 5. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs
in animals. Nat Rev Mol Cell Biol 2009; 10:126-139.
- 6. Bak M, Silahtaroglu A, Moller M, et al. MicroRNA
expression in the adult mouse central nervous
system. RNA 2008; 14:432-444.
- 7. Lugli G, Larson J, Demars MP, Smalheiser NR.
Primary microRNA precursor transcripts are
localized at post-synaptic densities in adult mouse
forebrain. J Neurochem 2012; 123:459-466.
- 8. Li S, Patel DJ. Drosha and Dicer: Slicers cut from the
same cloth. Cell Res 2016; 26:511-512.
- 9. Barbee SA, Estes PS, Cziko AM, et al. FMRPcontaining neuronal RNPs are structurally and
functionally related to somatic P bodies. Neuron
2006; 52:997-1009.
- 10. Kim J, Krichevsky A, Grad Y, et al. Identification of
many microRNAs that copurify with polyribosomes
in mammalian neurons. Proc Natl Acad Sci U S A
2004; 101:360-36.
- 11. Redondo RL, Morris RG. Making memories last: the
synaptic tagging and capture hypothesis. Nat Rev
Neurosci 2011; 12:17-30.
- 12. Junn E, Mouradian MM. MicroRNAs in
Neurodegenerative Diseases and Their Therapeutic
Potential. Pharmacol Ther 2012; 133:142-150.
- 13. Bredy TW, Lin Q, Wei W, Baker-Andresen D,
Mattick JS. MicroRNA regulation of neural plasticity
and memory. Neurobiol Learn Mem 2011; 96:89-
94.
- 14. Borchert GM, Lanier W, Davidson BL. RNA
polymerase III transcribes human microRNAs. Nat
Struct Mol Biol 2006; 13:1097-1101.
- 15. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5
mediates the nuclear export of pre-microRNAs and
short hairpin RNAs. Genes Dev 2003; 17:3011-
3016.
- 16. Lee YS, Nakahara K, Pham JW, et al. Distinct roles
for Drosophila Dicer-1 and Dicer-2 in the siRNA/
miRNA silencing pathways. Cell 2004; 117:69-81.
- 17. Lin S and Gregory RI. MicroRNA biogenesis
pathways in cancer. Nature Reviews Cancer 2015;
15:321-333.
- 18. Bartel DP. MicroRNAs: target recognition and
regulatory functions. Cell 2009; 136:215-233.
- 19. Wanet A, Tacheny A, Arnould T, Renard P. miR212/132 expression and functions: within and
beyond the neuronal compartment. Nucleic Acids
Res 2012; 40:4742-4753.
- 20. Vo N, Klein ME, Varlamova O, et al. A cAMPresponse element binding protein-induced
microRNA regulates neuronal morphogenesis. Proc
Natl Acad Sci U S A 2005; 102:16426-16431.
- 21. Wayman GA, Davare M, Ando H, et al. An activityregulated microRNA controls dendritic plasticity by
down-regulating p250GAP. Proc Natl Acad Sci
2008; 105:9093-9098.
- 22. Nudelman AS, DiRocco DP, Lambert TJ, et al.
Neuronal activity rapidly induces transcription of
the CREB-regulated microRNA-132, in vivo.
Hippocampus 2010; 20:492-498.
- 23. Mellios N, Sugihara H, Castro J, et al. miR-132, an
experience-dependent microRNA, is essential for
visual cortex plasticity. Nat Neurosci 2011;
14:1240-1242.
- 24. Hansen KF, Karelina K, Sakamoto K, et al. miRNA132: a dynamic regulator of cognitive capacity.
Brain Struct Funct 2013; 218:817-831.
- 25. Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, et al.
miRNA Expression profile after status epilepticus
and hippocampal neuroprotection by targeting miR
-132. Am J Pathol 2011; 179:2519-2532.
- 26. Dhar M, Zhu M, Impey S, et al. Leptin induces
hippocampal synaptogenesis via CREB-regulated
microRNA-132 suppression of p250GAP. Mol
Endocrinol 2014; 28:1073-1087.
- 27. Fan G, Hutnick L. Methyl- CpG binding proteins in
the nervous system. Cell Res 2005; 15:255-261.
- 28. Adkins NL, Georgel PT. MeCP2: structure and
function. Biochem Cell Biol 2011; 89:1-11
- 30. Hernandez-Rapp J, Smith PY, Filali M, et al. Memory
formation and retention are affected in adult miR132/212 knockout mice. Behav Brain Res 2015;
287:15-26.
- 31. Hansen KF, Sakamoto K, Aten S, et al. Targeted
deletion of miR-132/-212 impairs memory and
alters the hippocampal transcriptome. Learn Mem
2016; 23:61-71.
- 32. Jasińska M, Miłek J, Cymerman IA, Łęski S,
Kaczmarek L, Dziembowska M. miR-132 Regulates
Dendritic Spine Structure by Direct Targeting of
Matrix Metalloproteinase 9 mRNA. Mol Neurobiol
2016; 53:4701-4712.
- 33. Eacker SM, Keuss MJ, Berezikov E, Dawson VL,
Dawson TM. Neuronal activity regulates
hippocampal miRNA expression. PloS One 2011;
6:e25068.
- 34. Åkerblom M, Sachdeva R, Barde I, et al. MicroRNA124 is a subventricular zone neuronal fate determinant. J Neurosci 2012; 32:8879-8889.
- 35. Rajasethupathy P, Fiumara F, Sheridan R, et al.
Characterization of small RNAs in Aplysia reveals a
role for miR-124 in constraining synaptic plasticity
through CREB. Neuron 2009; 63:803-817.
- 36. Yang Y, Shu X, Liu D, et al. EPAC null mutation
impairs learning and social interactions via
aberrant regulation of miR-124 and Zif268
translation. Neuron 2012; 73:774-788.
- 37. Motti D, Bixby JL, Lemmon VP. MicroRNAs and
neuronal development. Semin Fetal Neonatal Med
2012; 17:347-352.
- 38. Giusti SA, Vogl AM, Brockmann MM, et al.
MicroRNA-9 controls dendritic development by
targeting REST. eLife 2014; 3:1-22.
- 39. Sim SE, Lim CS, Kim JI, et al. The Brain-Enriched
MicroRNA miR-9-3p Regulates Synaptic Plasticity
and Memory. J Neurosci 2016; 36:8641-8652.
- 40. Malmevik J, Petri R, Knauff P, et al. Distinct
cognitive effects and underlying transcriptome
changes upon inhibition of individual miRNAs in
hippocampal neurons. Scientific Reports 2016; 6:1-
14.
- 41. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini
ME, Kiebler M, Greenberg ME. A brain-specific
microRNA regulates dendritic spine development.
Nature 2006; 439: 283-289.
- 42. Siegel G, Obernosterer G, Fiore R, et al. A functional
screen implicates microRNA-138-dependent
regulation of the depalmitoylation enzyme APT1 in
dendritic spine morphogenesis. Nat Cell Biol 2009;
11:705-716.
- 43. Griggs EM, Young EJ, Rumbaugh G, Miller CA.
MicroRNA-182 regulates amygdala-dependent
memory formation. J Neurosci 2013; 33:1734-
1740.
- 44. Woldemichael BT, Jawaid A, Kremer EA, et al. The
microRNA cluster miR-183/96/182 contributes to
long-term memory in a protein phosphatase 1-
dependent manner. Nat Commun 2016; 25:12594.
- 45. Edbauer D, Neilson JR, Foster KA, et al. Regulation
of synaptic structure and function by FMRPassociated microRNAs miR-125b and miR-132.
Neuron 2010; 65:373-384.
- 46. Lin Q, Wei W, Coelho CM, et al. The brain-specific
microRNA miR-128b regulates the formation of
fear-extinction memory. Nat Neurosci 2011;
14:1115-1117.
- 47. Gao J, Wang WY, Mao YW, et al. A novel pathway
regulates memory and plasticity via SIRT1 and
miR-134. Nature 2010; 466:1105-1109.
- 48. Fiore R, Khudayberdiev S, Christensen M, et al.
Mef2-mediated transcription of the miR379–410
cluster regulates activity-dependent
dendritogenesis by fine-tuning Pumilio2 protein
levels. EMBO J 2009; 28:697-710.
- 49. Smrt RD, Szulwach KE, Pfeiffer RL, et al. MicroRNA
miR-137 regulates neuronal maturation by
targeting ubiquitin ligase mind bomb-1. Stem Cells
2010; 28:1060-1070.
- 50. Ripke S, Sanders AR, Kendler KS, et al. Genomewide association study identifies five new
schizophrenia loci. Nat Genet 2011; 43:969-976.
- 51. Li Y, Li S, Yan J, et al. miR-182 (microRNA-182)
suppression in the hippocampus evokes
antidepressant-like effects in rats. Prog
Neuropsychopharmacol Biol Psychiatry 2016;
4:96-103.
- 52. Kocerha J, Faghihi MA, Lopez-Toledano MA, et al.
MicroRNA-219 modulates NMDA receptormediated neurobehavioral dysfunction. Proc Natl
Acad Sci 2009; 106:3507-3512.
- 53. Barak B, Shvarts-Serebro I, Modai S, et al.
Opposing actions of environmental enrichment
and Alzheimer's disease on the expression of
hippocampal microRNAs in mouse models. Transl
Psychiatry 2013; 3:1-13.
- 54. Santulli G. microRNA: Medical Evidence From
Molecular Biology to Clinical Practice. In: Qiu L,
Tan EK, Zeng L (eds), microRNAs and
Neurodegenerative Diseases. Springer
International Publishing, Switzerland 2015, pp 85-
107.
- 55. Johnson R, Noble W, Tartaglia GG, Buckley NJ.
Neurodegeneration as an RNA disorder. Prog
Neurobiol 2012; 99:293-315.
- 56. Hernandez-Rapp J, Rainone S, Hébert SS.
MicroRNAs underlying memory deficits in
neurodegenerative disorders. Prog
Neuropsychopharmacol Biol Psychiatry
2017;73:79-86.
- 57. Ballard C, Gauthier S, Corbett A, Brayne C,
Aarsland D, Jones E. Alzheimer's disease. Lancet
2011; 377:1019-31.
- 58. Karch CM, Goate AM. Alzheimer’s disease risk
genes and mechanisms of disease pathogenesis.
Biol Psychiatry 2015; 77:43-51.
- 59. Lukiw WJ. Micro-RNA speciation in fetal, adult and
Alzheimer’s disease hippocampus. Neuroreport
2007;18:297-300.
- 60. Wang WX, Rajeev BW, Stromberg AJ, et al. The
expression of microRNA miR-107 decreases early
in Alzheimer’s disease and may accelerate disease
progression through regulation of β-site amyloid
precursor protein-cleaving enzyme 1. J Neurosci
2008; 28:1213-1223.
- 61. Smith P, A Hashimi A, Girard J, Delay C, Hebert SS.
In vivo regulation of amyloid precursor protein
neuronal splicing by microRNAs. J Neurochem
2011; 116:240-247.
- 62. Hebert SS, Horre K, Nicolai L, et al. Loss of
microRNA cluster miR-29a/b-1 in sporadic
Alzheimer’s disease correlates with increased
BACE1/beta-secretase expression. Proc Natl Acad
Sci U S A 2008; 105:6415-6420.
- 63. Lee ST, Chu K, Jung KH, et al. miR-206 regulates
brain-derived neurotrophic factor in Alzheimer
disease model. Ann Neurol 2012; 72: 269-277.
- 64. Müller M, Kuiperij HB, Claassen JA, Küsters B,
Verbeek MM. MicroRNAs in Alzheimer’s disease:
differential expression in hippocampus and cellfree cerebrospinal fluid. Neurobiol Aging 2014;
35:152-158.
- 65. Kumar S, Reddy PH. Are circulating microRNAs
peripheral biomarkers for Alzheimer's disease? Bio
chim Biophys Acta 2016; 1862:1617-1627.
- 66. Shtilbans A, Henchcliffe C.
BiomarkersinParkinson’sdisease: an update. Curr
Opin Neurol 2012; 25:460-465.
- 67. Dawson TM, Dawson VL. Molecular pathways of
neurodegeneration in Parkinson’s disease. Science
2003; 302:819-822.
- 68. Aarsland, D. Cognitive impairment in Parkinson's
disease and dementia with Lewy bodies.
Parkinsonism Relat Disord 2016; 22:144-148.
- 69. Kim J, Inoue K, Ishii J, et al. A MicroRNA feedback
circuit in midbrain dopamine neurons. Science
2007; 317:1220-1224.
- 70. Wang W, Kwon EJ, Tsai HL. MicroRNAs in learning,
memory, and neurological diseases. Learn Mem
2012; 19:359-368.
- 71. Minones-Moyano E, Porta S, Escaramís G, et al.
MicroRNA profiling of Parkinson’s disease brains
identifies early downregulation of miR-34b/c
which modulate mitochondrial function. Hum Mol
Genet 2011; 20:3067-3078.
- 72. Kabaria S, Choi DC, Chaudhuri AD, Mouradian MM,
Junn E. Inhibition of miR-34b and miR-34c
enhances α-synuclein expression in Parkinson's
disease. FEBS Lett 2015; 589:319-325.
- 73. Wang H, Ye Y, Zhu Z, et al. MiR-124 Regulates
Apoptosis and Autophagy Process in MPTP Model
of Parkinson's Disease by Targeting to Bim. Brain
Pathol 2016; 26: 167-176.
- 74. Maciotta S, Meregalli M, Torrente Y. The
involvement of microRNAs in neurodegenerative
diseases. Front Cell Neurosci 2013; 7:1-17.
- 75. Savas JN, Makusky A, Ottosen S, et al. Huntington's
disease protein contributes to RNA-mediated gene
silencing through association with Argonaute and P
bodies. Proc Natl Acad Sci USA 2008; 105:10820-
10825.
- 76. Johnson R, Zuccato C, Belyaev ND, et al. A
microRNA-based gene dysregulation pathway in
Huntington’s disease. Neurobiol Dis 2008; 29:438-
445.
- 77. Zuccato C, Tartari M, Crotti A, et al. Huntingtin
interacts with REST/NRSF to modulate the
transcription of NRSE-controlled neuronal genes.
Nat Genet 2003; 35:76-83.
- 78. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL.
The bifunctional microRNA miR-9/miR-9*
regulates REST and CoREST and is downregulated
in Huntington's disease. J Neurosci 2008; 28:14341
-14346.
- 79. Jin P, Warren ST. Understanding the molecular
basis of fragile X syndrome. Hum Mol Genet 2000;
9:901-908.
- 80. Campos-Melo D, Droppelmann CA, He Z, Volkening
K, Strong MJ. Altered microRNA expression profi le
in Amyotrophic Lateral Sclerosis: a role in the
regulation of NFL mRNA levels. Mol Brain 2013; 6:1
-13.
- 81. Koval ED, Shaner C, Zhang P, et al. Method for
widespread microRNA-155 inhibition prolongs
survival in ALSmodel mice. Hum Mol Genet 2013;
22:4127-4135.
- 82. Henshall DC. MicroRNA and epilepsy: profiling,
functions and potential clinical applications. Curr
Opin Neurol. 2014; 27:199-205.
- 83. Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of
microRNAs in vivo with ‘antagomirs’. Nature 2005;
438:685-689.
The Epıgenetıc Regulatıon Of Memory: The Role Of Mıcrornas
Yıl 2018,
Cilt: 27 Sayı: 1, 87 - 94, 01.03.2018
Sebahattin Karabulut
Keziban Korkmaz Bayramov
Asuman Gölgeli
Öz
“MicroRNAs (miRNAs)” are a class of non-coding RNAs
defined as posttranscriptional regulators of protein
synthesis. It is believed that this posttranscriptional
regulation has been implicated in virtually all aspects
of biological processes. Recently, it has been understood that miRNA-mediated regulation is critical for
learning and memory formation which requires activity-dependent gene expression. Emerging evidence
indicates that these endogenous RNAs are involved in
not only normal brain functions such as learning and
memory, but also the pathophysiology of many neurodegenerative diseases in which cognitive functions
are influenced. In this review, the roles of miRNAs in
synaptic plasticity and their relation to some neurodegenerative diseases are discussed. With further elaboration of the role of miRNAs in neural plasticity, the
door will be opened for the development of new diagnostic tests and genetic therapies for neurodegenerative diseases in which memory functions are impaired.”
Kaynakça
- 1. Benington JH, Frank MG. Cellular and molecular
connections between sleep and synaptic plasticity.
Prog Neurobiol 2003; 69:71-101.
- 2. Davis HP, Squire LR. Protein synthesis and
memory: a review. Psychol Bull 1984; 96:518-559.
- 3. Sutton MA, Schuman EM. Dendritic protein
synthesis, synaptic plasticity, and memory. Cell
2006; 127:49-58.
- 4. Bartel DP. MicroRNAs: genomics, biogenesis,
mechanism, and function. Cell 2004; 116:281-297.
- 5. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs
in animals. Nat Rev Mol Cell Biol 2009; 10:126-139.
- 6. Bak M, Silahtaroglu A, Moller M, et al. MicroRNA
expression in the adult mouse central nervous
system. RNA 2008; 14:432-444.
- 7. Lugli G, Larson J, Demars MP, Smalheiser NR.
Primary microRNA precursor transcripts are
localized at post-synaptic densities in adult mouse
forebrain. J Neurochem 2012; 123:459-466.
- 8. Li S, Patel DJ. Drosha and Dicer: Slicers cut from the
same cloth. Cell Res 2016; 26:511-512.
- 9. Barbee SA, Estes PS, Cziko AM, et al. FMRPcontaining neuronal RNPs are structurally and
functionally related to somatic P bodies. Neuron
2006; 52:997-1009.
- 10. Kim J, Krichevsky A, Grad Y, et al. Identification of
many microRNAs that copurify with polyribosomes
in mammalian neurons. Proc Natl Acad Sci U S A
2004; 101:360-36.
- 11. Redondo RL, Morris RG. Making memories last: the
synaptic tagging and capture hypothesis. Nat Rev
Neurosci 2011; 12:17-30.
- 12. Junn E, Mouradian MM. MicroRNAs in
Neurodegenerative Diseases and Their Therapeutic
Potential. Pharmacol Ther 2012; 133:142-150.
- 13. Bredy TW, Lin Q, Wei W, Baker-Andresen D,
Mattick JS. MicroRNA regulation of neural plasticity
and memory. Neurobiol Learn Mem 2011; 96:89-
94.
- 14. Borchert GM, Lanier W, Davidson BL. RNA
polymerase III transcribes human microRNAs. Nat
Struct Mol Biol 2006; 13:1097-1101.
- 15. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5
mediates the nuclear export of pre-microRNAs and
short hairpin RNAs. Genes Dev 2003; 17:3011-
3016.
- 16. Lee YS, Nakahara K, Pham JW, et al. Distinct roles
for Drosophila Dicer-1 and Dicer-2 in the siRNA/
miRNA silencing pathways. Cell 2004; 117:69-81.
- 17. Lin S and Gregory RI. MicroRNA biogenesis
pathways in cancer. Nature Reviews Cancer 2015;
15:321-333.
- 18. Bartel DP. MicroRNAs: target recognition and
regulatory functions. Cell 2009; 136:215-233.
- 19. Wanet A, Tacheny A, Arnould T, Renard P. miR212/132 expression and functions: within and
beyond the neuronal compartment. Nucleic Acids
Res 2012; 40:4742-4753.
- 20. Vo N, Klein ME, Varlamova O, et al. A cAMPresponse element binding protein-induced
microRNA regulates neuronal morphogenesis. Proc
Natl Acad Sci U S A 2005; 102:16426-16431.
- 21. Wayman GA, Davare M, Ando H, et al. An activityregulated microRNA controls dendritic plasticity by
down-regulating p250GAP. Proc Natl Acad Sci
2008; 105:9093-9098.
- 22. Nudelman AS, DiRocco DP, Lambert TJ, et al.
Neuronal activity rapidly induces transcription of
the CREB-regulated microRNA-132, in vivo.
Hippocampus 2010; 20:492-498.
- 23. Mellios N, Sugihara H, Castro J, et al. miR-132, an
experience-dependent microRNA, is essential for
visual cortex plasticity. Nat Neurosci 2011;
14:1240-1242.
- 24. Hansen KF, Karelina K, Sakamoto K, et al. miRNA132: a dynamic regulator of cognitive capacity.
Brain Struct Funct 2013; 218:817-831.
- 25. Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, et al.
miRNA Expression profile after status epilepticus
and hippocampal neuroprotection by targeting miR
-132. Am J Pathol 2011; 179:2519-2532.
- 26. Dhar M, Zhu M, Impey S, et al. Leptin induces
hippocampal synaptogenesis via CREB-regulated
microRNA-132 suppression of p250GAP. Mol
Endocrinol 2014; 28:1073-1087.
- 27. Fan G, Hutnick L. Methyl- CpG binding proteins in
the nervous system. Cell Res 2005; 15:255-261.
- 28. Adkins NL, Georgel PT. MeCP2: structure and
function. Biochem Cell Biol 2011; 89:1-11
- 30. Hernandez-Rapp J, Smith PY, Filali M, et al. Memory
formation and retention are affected in adult miR132/212 knockout mice. Behav Brain Res 2015;
287:15-26.
- 31. Hansen KF, Sakamoto K, Aten S, et al. Targeted
deletion of miR-132/-212 impairs memory and
alters the hippocampal transcriptome. Learn Mem
2016; 23:61-71.
- 32. Jasińska M, Miłek J, Cymerman IA, Łęski S,
Kaczmarek L, Dziembowska M. miR-132 Regulates
Dendritic Spine Structure by Direct Targeting of
Matrix Metalloproteinase 9 mRNA. Mol Neurobiol
2016; 53:4701-4712.
- 33. Eacker SM, Keuss MJ, Berezikov E, Dawson VL,
Dawson TM. Neuronal activity regulates
hippocampal miRNA expression. PloS One 2011;
6:e25068.
- 34. Åkerblom M, Sachdeva R, Barde I, et al. MicroRNA124 is a subventricular zone neuronal fate determinant. J Neurosci 2012; 32:8879-8889.
- 35. Rajasethupathy P, Fiumara F, Sheridan R, et al.
Characterization of small RNAs in Aplysia reveals a
role for miR-124 in constraining synaptic plasticity
through CREB. Neuron 2009; 63:803-817.
- 36. Yang Y, Shu X, Liu D, et al. EPAC null mutation
impairs learning and social interactions via
aberrant regulation of miR-124 and Zif268
translation. Neuron 2012; 73:774-788.
- 37. Motti D, Bixby JL, Lemmon VP. MicroRNAs and
neuronal development. Semin Fetal Neonatal Med
2012; 17:347-352.
- 38. Giusti SA, Vogl AM, Brockmann MM, et al.
MicroRNA-9 controls dendritic development by
targeting REST. eLife 2014; 3:1-22.
- 39. Sim SE, Lim CS, Kim JI, et al. The Brain-Enriched
MicroRNA miR-9-3p Regulates Synaptic Plasticity
and Memory. J Neurosci 2016; 36:8641-8652.
- 40. Malmevik J, Petri R, Knauff P, et al. Distinct
cognitive effects and underlying transcriptome
changes upon inhibition of individual miRNAs in
hippocampal neurons. Scientific Reports 2016; 6:1-
14.
- 41. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini
ME, Kiebler M, Greenberg ME. A brain-specific
microRNA regulates dendritic spine development.
Nature 2006; 439: 283-289.
- 42. Siegel G, Obernosterer G, Fiore R, et al. A functional
screen implicates microRNA-138-dependent
regulation of the depalmitoylation enzyme APT1 in
dendritic spine morphogenesis. Nat Cell Biol 2009;
11:705-716.
- 43. Griggs EM, Young EJ, Rumbaugh G, Miller CA.
MicroRNA-182 regulates amygdala-dependent
memory formation. J Neurosci 2013; 33:1734-
1740.
- 44. Woldemichael BT, Jawaid A, Kremer EA, et al. The
microRNA cluster miR-183/96/182 contributes to
long-term memory in a protein phosphatase 1-
dependent manner. Nat Commun 2016; 25:12594.
- 45. Edbauer D, Neilson JR, Foster KA, et al. Regulation
of synaptic structure and function by FMRPassociated microRNAs miR-125b and miR-132.
Neuron 2010; 65:373-384.
- 46. Lin Q, Wei W, Coelho CM, et al. The brain-specific
microRNA miR-128b regulates the formation of
fear-extinction memory. Nat Neurosci 2011;
14:1115-1117.
- 47. Gao J, Wang WY, Mao YW, et al. A novel pathway
regulates memory and plasticity via SIRT1 and
miR-134. Nature 2010; 466:1105-1109.
- 48. Fiore R, Khudayberdiev S, Christensen M, et al.
Mef2-mediated transcription of the miR379–410
cluster regulates activity-dependent
dendritogenesis by fine-tuning Pumilio2 protein
levels. EMBO J 2009; 28:697-710.
- 49. Smrt RD, Szulwach KE, Pfeiffer RL, et al. MicroRNA
miR-137 regulates neuronal maturation by
targeting ubiquitin ligase mind bomb-1. Stem Cells
2010; 28:1060-1070.
- 50. Ripke S, Sanders AR, Kendler KS, et al. Genomewide association study identifies five new
schizophrenia loci. Nat Genet 2011; 43:969-976.
- 51. Li Y, Li S, Yan J, et al. miR-182 (microRNA-182)
suppression in the hippocampus evokes
antidepressant-like effects in rats. Prog
Neuropsychopharmacol Biol Psychiatry 2016;
4:96-103.
- 52. Kocerha J, Faghihi MA, Lopez-Toledano MA, et al.
MicroRNA-219 modulates NMDA receptormediated neurobehavioral dysfunction. Proc Natl
Acad Sci 2009; 106:3507-3512.
- 53. Barak B, Shvarts-Serebro I, Modai S, et al.
Opposing actions of environmental enrichment
and Alzheimer's disease on the expression of
hippocampal microRNAs in mouse models. Transl
Psychiatry 2013; 3:1-13.
- 54. Santulli G. microRNA: Medical Evidence From
Molecular Biology to Clinical Practice. In: Qiu L,
Tan EK, Zeng L (eds), microRNAs and
Neurodegenerative Diseases. Springer
International Publishing, Switzerland 2015, pp 85-
107.
- 55. Johnson R, Noble W, Tartaglia GG, Buckley NJ.
Neurodegeneration as an RNA disorder. Prog
Neurobiol 2012; 99:293-315.
- 56. Hernandez-Rapp J, Rainone S, Hébert SS.
MicroRNAs underlying memory deficits in
neurodegenerative disorders. Prog
Neuropsychopharmacol Biol Psychiatry
2017;73:79-86.
- 57. Ballard C, Gauthier S, Corbett A, Brayne C,
Aarsland D, Jones E. Alzheimer's disease. Lancet
2011; 377:1019-31.
- 58. Karch CM, Goate AM. Alzheimer’s disease risk
genes and mechanisms of disease pathogenesis.
Biol Psychiatry 2015; 77:43-51.
- 59. Lukiw WJ. Micro-RNA speciation in fetal, adult and
Alzheimer’s disease hippocampus. Neuroreport
2007;18:297-300.
- 60. Wang WX, Rajeev BW, Stromberg AJ, et al. The
expression of microRNA miR-107 decreases early
in Alzheimer’s disease and may accelerate disease
progression through regulation of β-site amyloid
precursor protein-cleaving enzyme 1. J Neurosci
2008; 28:1213-1223.
- 61. Smith P, A Hashimi A, Girard J, Delay C, Hebert SS.
In vivo regulation of amyloid precursor protein
neuronal splicing by microRNAs. J Neurochem
2011; 116:240-247.
- 62. Hebert SS, Horre K, Nicolai L, et al. Loss of
microRNA cluster miR-29a/b-1 in sporadic
Alzheimer’s disease correlates with increased
BACE1/beta-secretase expression. Proc Natl Acad
Sci U S A 2008; 105:6415-6420.
- 63. Lee ST, Chu K, Jung KH, et al. miR-206 regulates
brain-derived neurotrophic factor in Alzheimer
disease model. Ann Neurol 2012; 72: 269-277.
- 64. Müller M, Kuiperij HB, Claassen JA, Küsters B,
Verbeek MM. MicroRNAs in Alzheimer’s disease:
differential expression in hippocampus and cellfree cerebrospinal fluid. Neurobiol Aging 2014;
35:152-158.
- 65. Kumar S, Reddy PH. Are circulating microRNAs
peripheral biomarkers for Alzheimer's disease? Bio
chim Biophys Acta 2016; 1862:1617-1627.
- 66. Shtilbans A, Henchcliffe C.
BiomarkersinParkinson’sdisease: an update. Curr
Opin Neurol 2012; 25:460-465.
- 67. Dawson TM, Dawson VL. Molecular pathways of
neurodegeneration in Parkinson’s disease. Science
2003; 302:819-822.
- 68. Aarsland, D. Cognitive impairment in Parkinson's
disease and dementia with Lewy bodies.
Parkinsonism Relat Disord 2016; 22:144-148.
- 69. Kim J, Inoue K, Ishii J, et al. A MicroRNA feedback
circuit in midbrain dopamine neurons. Science
2007; 317:1220-1224.
- 70. Wang W, Kwon EJ, Tsai HL. MicroRNAs in learning,
memory, and neurological diseases. Learn Mem
2012; 19:359-368.
- 71. Minones-Moyano E, Porta S, Escaramís G, et al.
MicroRNA profiling of Parkinson’s disease brains
identifies early downregulation of miR-34b/c
which modulate mitochondrial function. Hum Mol
Genet 2011; 20:3067-3078.
- 72. Kabaria S, Choi DC, Chaudhuri AD, Mouradian MM,
Junn E. Inhibition of miR-34b and miR-34c
enhances α-synuclein expression in Parkinson's
disease. FEBS Lett 2015; 589:319-325.
- 73. Wang H, Ye Y, Zhu Z, et al. MiR-124 Regulates
Apoptosis and Autophagy Process in MPTP Model
of Parkinson's Disease by Targeting to Bim. Brain
Pathol 2016; 26: 167-176.
- 74. Maciotta S, Meregalli M, Torrente Y. The
involvement of microRNAs in neurodegenerative
diseases. Front Cell Neurosci 2013; 7:1-17.
- 75. Savas JN, Makusky A, Ottosen S, et al. Huntington's
disease protein contributes to RNA-mediated gene
silencing through association with Argonaute and P
bodies. Proc Natl Acad Sci USA 2008; 105:10820-
10825.
- 76. Johnson R, Zuccato C, Belyaev ND, et al. A
microRNA-based gene dysregulation pathway in
Huntington’s disease. Neurobiol Dis 2008; 29:438-
445.
- 77. Zuccato C, Tartari M, Crotti A, et al. Huntingtin
interacts with REST/NRSF to modulate the
transcription of NRSE-controlled neuronal genes.
Nat Genet 2003; 35:76-83.
- 78. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL.
The bifunctional microRNA miR-9/miR-9*
regulates REST and CoREST and is downregulated
in Huntington's disease. J Neurosci 2008; 28:14341
-14346.
- 79. Jin P, Warren ST. Understanding the molecular
basis of fragile X syndrome. Hum Mol Genet 2000;
9:901-908.
- 80. Campos-Melo D, Droppelmann CA, He Z, Volkening
K, Strong MJ. Altered microRNA expression profi le
in Amyotrophic Lateral Sclerosis: a role in the
regulation of NFL mRNA levels. Mol Brain 2013; 6:1
-13.
- 81. Koval ED, Shaner C, Zhang P, et al. Method for
widespread microRNA-155 inhibition prolongs
survival in ALSmodel mice. Hum Mol Genet 2013;
22:4127-4135.
- 82. Henshall DC. MicroRNA and epilepsy: profiling,
functions and potential clinical applications. Curr
Opin Neurol. 2014; 27:199-205.
- 83. Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of
microRNAs in vivo with ‘antagomirs’. Nature 2005;
438:685-689.